Recent developments in cholera

Current Opinion in Infectious Diseases

Volumn 14, Issue 5, 2001, Pages 553-558

  Shears, Paul ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; CHOLERA TOXIN; CHOLERA VACCINE;

ANTIBIOTIC RESISTANCE; CHOLERA; ENVIRONMENTAL FACTOR; GENE CONTROL; HUMAN; PATHOGENICITY; REHYDRATION; REVIEW; VIBRIO CHOLERAE;

EID: 0034811061     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200110000-00008     Document Type: Review

References (63)

1. Cholera in the 1990s
2. DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae
3. Sunlight-induced propagation of the lysogenic phage encoding cholera toxin
4. Altered expression of the ToxR-regulated porins OmpU and OmpT diminishes Vibrio cholerae bile resistance, virulence factor expression, and intestinal colonization
5. PepA, a gene mediating pH regulation of virulence genes in Vibrio cholerae
6. Analysis of an autoregulatory loop controlling ToxT, cholera toxin, and toxin coregulated pilus production in Vibrio cholerae
7. Pathogenic and vaccine significance of toxin-coregulated pili of Vibrio cholerae El Tor
8. Environmental signals modulate ToxT-dependent virulence factor expression in Vibrio cholerae
9. Mechanisms of cholera toxin-induced diarrhoea
10. Ecological study of Vibrio cholerae in Vellore
11. Virulence genes in environmental strains of Vibrio cholerae
12. Detection of virulence associated genes, haemolysis and protease amongst Vibrio cholerae isolated in Malaysia
13. Cholera dynamics and El Niño-Southern Oscillation
14. From the cover: Climate and infectious disease: Use of remote sensing for detection of Vibrio cholerae by indirect measurement
15. Spatial distribution of watery diarrhoea in children: Identification of 'risk areas' in a rural community in Bangladesh
16. Global climate and infectious disease: The cholera paradigm
17. Genomic diversity among Vibrio cholerae O139 strains isolated in Bangladesh and India between 1992 and 1998
18. Genetic diversity of clinical and environmental isolates of Vibrio cholerae determined by amplified fragment length polymorphism fingerprinting
19. Molecular evidence of clonality amongst Vibrio cholerae O1 biotype El Tor during an outbreak in Malaysia
20. Phenotypic and molecular characterization of Vibrio cholerae O1 isolated in Samutsakorn, Thailand before, during and after the emergence of V. cholerae O139
21. The O139 serogroup of Vibrio cholerae comprises diverse clones of epidemic and nonepidemic strains derived from multiple V. cholerae O1 or non-O1 progenitors
22. Transmission of epidemic Vibrio cholerae O1 in rural western Kenya associated with drinking water from Lake Victoria: An environmental reservoir for cholera?
23. Food as a vehicle of transmission of cholera
24. Vector potential of houseflies (Musca domestica) in the transmission of Vibrio cholerae in India
25. Epidemic cholera in Guinea-Bissau: The challenge of preventing deaths in rural West Africa
26. Endemic cholera in Chad: A real public health problem
27. Diarrhoeal disease risk in Matlab, Bangladesh
28. Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: A randomised double blind clinical trial
29. Reduced-osmolarity oral rehydration salts solution multicentre trial: Implications for national policy
30. First do no harm: Making oral rehydration solution safer in a cholera epidemic
31. Sacolene in cholera: A double blind randomized controlled trial
32. Protection from cholera by adding lime juice to food - Result from community and laboratory studies in Guinea-Bissau, west Africa
33. Cholera in north Brazil: On the occurrence of strains of Vibrio cholerae O1 which fail to ferment sucrose during routine plating on thiosulphate-citrate-bile salt-sucrose agar (TCBS). A new problem in diagnosis and control?
34. An improved method for detecting faecal Vibrio cholerae by PCR of the toxin A gene
35. Rapid method for species-specific identification of Vibrio cholerae using primers targeted to the gene of outer membrane protein Omp W
36. Detection of toxigenic Vibrio cholerae from environmental water samples by an enrichment broth cultivation-pit-stop semi-nested PCR procedure
37. Detection of etiological agent for cholera by PCR protocol
38. Application of PCR for detection of toxigenic Vibrio cholerae O1 in water samples during an outbreak of cholera
39. Evaluation of the cholera spot test: A chromatographic immunoassay for the rapid detection of cholera antigen
40. Antibiotic resistance pattern of Vibrio cholerae and Shigella causing diarrhoea outbreaks in the eastern Africa region: 1994-1996
41. Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-7 in Calcutta, India
42. Cluster-analysis and patterns of dissemination of multidrug resistance among clinical strains of Vibrio cholerae in Calcutta, India
43. Clinical features, antimicrobial susceptibility and toxin production in Vibrio cholerae O139 infection: Comparison with V. cholerae O1 infection
44. Outbreak of cholera caused by Vibrio cholerae O1 intermediately resistant to norfloxacin at Malda, West Bengal
45. Antibiotic resistance conferred by a conjugative plasmid and a class I integron in Vibrio cholerae O1 El Tor strains isolated in Albania and Italy
46. Inc J plasmids identified for the first time in Vibrio cholerae El Tor
47. Class 1 integron-borne, multiple-antibiotic resistance encoded by a 150-kilobase conjugative plasmid in epidemic Vibrio cholerae O1 strains isolated in Guinea-Bissau
48. Cholera in Vietnam: Changes in genotypes and emergence of class I integrons containing aminoglycoside resistance gene cassettes in Vibrio cholerae O1 strains isolated from 1979 to 1996
49. Epidemiology and surveillance of antimicrobial resistance in the tropics
50. Cholera vaccines
51. Antibodies (IgG) to lipopolysaccharide of Vibrio cholerae O1 mediate protection through inhibition of intestinal adherence and colonisation in a mouse model
52. Field trial of inactivated oral cholera vaccines in Bangladesh: Results from 5 years of follow-up
53. Safety, immunogenicity, and lot stability of the whole cell/recombinant B subunit (WC/rCTB) cholera vaccine in Peruvian adults and children
54. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru
55. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor inaba three months after vaccination
56. Efficacy trial of single-dose live oral cholera vaccine CVD HgR in North Jakarta, Indonesia, a cholera-endemic area
57. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children
58. Construction and characterization of a nonproliferative El Tor cholera vaccine candidate derived from strain 638
59. Antibodies to the truncated (short) form of 'O' polysaccharides (TFOP) of Vibrio cholerae O139 lipopolysaccharides protect mice against experimental cholera induced by encapsulated O139 strains and such protection is mediated by inhibition of intestinal colonization of vibrios
60. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp
61. Prevention fails to halt South Africa's well-treated cholera epidemic